NO144885C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater

Info

Publication number
NO144885C
NO144885C NO793013A NO793013A NO144885C NO 144885 C NO144885 C NO 144885C NO 793013 A NO793013 A NO 793013A NO 793013 A NO793013 A NO 793013A NO 144885 C NO144885 C NO 144885C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
benzodiazepine derivatives
analogy procedure
active benzodiazepine
Prior art date
Application number
NO793013A
Other languages
English (en)
Other versions
NO144885B (no
NO793013L (no
Inventor
Wolfgang Milkowski
Renke Budden
Siegfried Funke
Rolf Hueschens
Hans-Guenther Liepmann
Werner Stuehmer
Horst Zeugner
Original Assignee
Kali Chemie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO793013L publication Critical patent/NO793013L/no
Application filed by Kali Chemie Ag filed Critical Kali Chemie Ag
Publication of NO144885B publication Critical patent/NO144885B/no
Publication of NO144885C publication Critical patent/NO144885C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/5545—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D245/06—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO793013A 1972-05-03 1979-09-19 Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater NO144885C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2221558A DE2221558C2 (de) 1972-05-03 1972-05-03 5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepine und ihre Säureadditionssalze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (3)

Publication Number Publication Date
NO793013L NO793013L (no) 1973-11-06
NO144885B NO144885B (no) 1981-08-24
NO144885C true NO144885C (no) 1981-12-02

Family

ID=5843904

Family Applications (6)

Application Number Title Priority Date Filing Date
NO1797/73A NO142866C (no) 1972-05-03 1973-05-02 Nye benzodiazepinderivater for anvendelse som ugangsmateriale og fremgangsmaate ved fremstilling derav
NO75751349A NO145761C (no) 1972-05-03 1975-04-16 Benzodiazocinderivater for anvendelse som utgangsmaterialer ved fremstilling av benzodiazepinderivater, og en ny fremgangsmaate for fremstilling av disse benzodiazocinderivater
NO76761580A NO143347C (no) 1972-05-03 1976-05-07 Utgangsmateriale for fremstilling av benzodiazepinderivater
NO780402A NO142476C (no) 1972-05-03 1978-02-06 Fremgangsmaate ved fremstilling av benzodiazepinderivater
NO793012A NO144386C (no) 1972-05-03 1979-09-19 Fremgangsmaate ved fremstilling av benzodiazepinderivater
NO793013A NO144885C (no) 1972-05-03 1979-09-19 Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater

Family Applications Before (5)

Application Number Title Priority Date Filing Date
NO1797/73A NO142866C (no) 1972-05-03 1973-05-02 Nye benzodiazepinderivater for anvendelse som ugangsmateriale og fremgangsmaate ved fremstilling derav
NO75751349A NO145761C (no) 1972-05-03 1975-04-16 Benzodiazocinderivater for anvendelse som utgangsmaterialer ved fremstilling av benzodiazepinderivater, og en ny fremgangsmaate for fremstilling av disse benzodiazocinderivater
NO76761580A NO143347C (no) 1972-05-03 1976-05-07 Utgangsmateriale for fremstilling av benzodiazepinderivater
NO780402A NO142476C (no) 1972-05-03 1978-02-06 Fremgangsmaate ved fremstilling av benzodiazepinderivater
NO793012A NO144386C (no) 1972-05-03 1979-09-19 Fremgangsmaate ved fremstilling av benzodiazepinderivater

Country Status (18)

Country Link
US (6) US3998809A (no)
JP (3) JPS5541231B2 (no)
AT (3) AT327927B (no)
BE (1) BE799001A (no)
CA (3) CA1009232A (no)
CH (5) CH611608A5 (no)
DD (1) DD105222A5 (no)
DE (3) DE2265371C3 (no)
DK (3) DK147050C (no)
ES (1) ES414279A1 (no)
FR (3) FR2183735B1 (no)
GB (3) GB1429666A (no)
IL (5) IL48141A (no)
NL (1) NL179111C (no)
NO (6) NO142866C (no)
SE (3) SE409709B (no)
SU (2) SU526290A3 (no)
ZA (1) ZA733013B (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2265371C3 (de) * 1972-05-03 1980-12-11 Kali-Chemie Ag, 3000 Hannover N-(3-Benzoylaminopropyl)-aniline
US4244869A (en) * 1972-05-03 1981-01-13 Kali-Chemie A.G. Benzodiazepine derivatives and process of making them
DE2520937C3 (de) * 1975-05-10 1978-10-12 Kali-Chemie Ag, 3000 Hannover 7-Brom-1 -methyl^-alkoxymethyl-S-(2-halogenphenyl)-lH-23-dihydro-l,4benzodiazepinderivate, deren Säureadditionssalze und pharmazeutische Präparate
DE2720968C2 (de) * 1977-05-10 1986-05-07 Kali-Chemie Pharma Gmbh, 3000 Hannover N↓1↓-Acyl-2-hydroxy-1,3-diaminopropane und Arzneimittel
DE2720908A1 (de) * 1977-05-10 1978-11-23 Kali Chemie Pharma Gmbh Arzneimittel mit ulkustherapeutischem effekt
ES469020A1 (es) * 1977-05-10 1979-09-01 Kali Chemie Pharma Gmbh Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos
US4123430A (en) * 1977-11-10 1978-10-31 G. D. Searle & Co. 2-Aryl-4-(1-piperazinyl)-3H-1,5-benzodiazepines
DE2754112A1 (de) * 1977-12-05 1979-06-13 Kali Chemie Pharma Gmbh 1,4-benzodiazepinderivate, ihre salze und diese verbindungen enthaltende arzneipraeparate
DE2810349A1 (de) * 1978-03-10 1979-09-20 Kali Chemie Pharma Gmbh Verfahren zur herstellung von 3-hydroxy-6-phenyl-1,2,3,4-tetrahydro- 1,5-benzodiazocinen
US4368157A (en) * 1978-05-15 1983-01-11 Hoffmann-La Roche Inc. Intermediates to produce imidazodiazepines
US4368158A (en) * 1978-05-15 1983-01-11 Hoffmann-La Roche Inc. Intermediates to produce imidazodiazepines
US4368159A (en) * 1978-05-15 1983-01-11 Hoffmann-La Roche Inc. Intermediates to produce imidazodiazepines
US4371468A (en) * 1978-05-15 1983-02-01 Hoffmann-La Roche Inc. Intermediates to produce imidazodiazepines
DE2827801A1 (de) * 1978-06-24 1980-01-10 Kali Chemie Pharma Gmbh Neue n tief 1 -benzoyl-n tief 2 -phenyl-1,3-diaminopropan-2-ole, verfahren zu deren herstellung und arzneimittel
DE2835708A1 (de) * 1978-08-16 1980-03-06 Kali Chemie Pharma Gmbh Neue eckige klammer auf 1,2 eckige klammer zu-anellierte 7-phenyl-1,4-benzodiazepinderivate, verfahren zu deren herstellung und arzneimittel
JPS5775313A (en) * 1980-10-30 1982-05-11 Fanuc Ltd Numerical controller of machine tool
DE3048264A1 (de) * 1980-12-20 1982-09-09 Kali-Chemie Pharma Gmbh, 3000 Hannover 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3124013A1 (de) * 1981-06-19 1982-12-30 Kali-Chemie Pharma Gmbh, 3000 Hannover 2-acylaminomethyl-1,4-benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3138769A1 (de) * 1981-09-30 1983-04-14 Kali-Chemie Pharma Gmbh, 3000 Hannover 7-brom-5-(2-halogenphenyl)-1h-2,3-dihydro-1,4- benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3151597A1 (de) * 1981-12-28 1983-07-07 Kali-Chemie Pharma Gmbh, 3000 Hannover (1,2)-anellierte 1,4-benzodiazepin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3221402A1 (de) * 1982-06-05 1983-12-08 Kali-Chemie Pharma Gmbh, 3000 Hannover 5-phenyl-1,4-benzodiazepine enthaltende analgetisch wirksame pharmazeutische zubereitungen
US4493168A (en) * 1983-06-16 1985-01-15 Coburn Optical Industries, Inc. Calibration gauge for computer-controlled lens generator, or the like
US4602886A (en) * 1983-12-28 1986-07-29 Smit Adrianus J Multi-color marking implement
US4786449A (en) * 1983-12-28 1988-11-22 Clowny Corporation Method for manufacture of multi-color marking implements
EP0170024A3 (en) * 1984-06-26 1990-01-31 Merck & Co. Inc. Use of 2-acylaminomethyl-1,4-benzodiazepine derivatives for the production of pharmaceutical compositions and process for the preparation for pharmaceutical compositions
US4684646A (en) * 1984-06-26 1987-08-04 Merck & Co., Inc. 2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagonists
US4724237A (en) * 1984-06-26 1988-02-09 Merck & Co., Inc. 2-substituted-aminomethyl-1,4-benzodiazepines
JPS61114933A (ja) * 1984-11-12 1986-06-02 Tokyo Electric Co Ltd 事務機の給紙装置
JPH0618794Y2 (ja) * 1987-06-17 1994-05-18 株式会社スギノマシン ウォータジェット加工機
JPH0418564Y2 (no) * 1988-01-08 1992-04-24
US5856497A (en) * 1995-12-11 1999-01-05 Boehringer Ingelheim Pharmaceuticals, Inc. Asymmetric synthesis of α-cycloalkylalkyl substituted methanamines
US5670640A (en) * 1996-02-02 1997-09-23 Hoffmann-La Roche Inc. Process for the manufacture of imidazodiazepine derivatives
US5831089A (en) * 1996-07-01 1998-11-03 Pharmacia & Upjohn Company Process to produce midazolam
US6818607B1 (en) * 1999-08-27 2004-11-16 Procter & Gamble Company Bleach boosting components, compositions and laundry methods
US7109156B1 (en) 1999-08-27 2006-09-19 Procter & Gamble Company Controlled availability of formulation components, compositions and laundry methods employing same
US6825160B1 (en) 1999-08-27 2004-11-30 Procter & Gamble Company Color safe laundry methods employing cationic formulation components
WO2001016276A1 (en) 1999-08-27 2001-03-08 The Procter & Gamble Company Stability enhancing formulation components, compositions and laundry methods employing same
US6821935B1 (en) 1999-08-27 2004-11-23 Procter & Gamble Company Color safe laundry methods employing zwitterionic formulation components
MXPA02002129A (es) * 1999-08-27 2002-09-18 Procter & Gamble Componentes de formulacion de accion rapida, composiciones y metodos para lavanderia que los emplean.
US6903060B1 (en) 1999-08-27 2005-06-07 Procter & Gamble Company Stable formulation components, compositions and laundry methods employing same
JP2003510251A (ja) * 1999-08-27 2003-03-18 ザ、プロクター、エンド、ギャンブル、カンパニー ブリーチ増強成分、組成物および洗濯方法
US7169744B2 (en) 2002-06-06 2007-01-30 Procter & Gamble Company Organic catalyst with enhanced solubility
US7557076B2 (en) * 2002-06-06 2009-07-07 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
US20050113246A1 (en) * 2003-11-06 2005-05-26 The Procter & Gamble Company Process of producing an organic catalyst
AR051659A1 (es) * 2005-06-17 2007-01-31 Procter & Gamble Una composicion que comprende un catalizador organico con compatibilidada enzimatica mejorada

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2721215A (en) * 1952-06-12 1955-10-18 Hoffmann La Rache Inc Diphenylacetyl diamines
US2785200A (en) * 1953-06-08 1957-03-12 Abbott Lab Dichlorobenzoyl-ethylenediamine
US2721214A (en) * 1953-06-09 1955-10-18 Parke Davis & Co Process for producing acylamido diols
US3576868A (en) * 1966-06-03 1971-04-27 Hoffmann La Roche Benzoyl amino ethyl aniline derivatives
US3501460A (en) * 1966-06-03 1970-03-17 Hoffmann La Roche Dehydration process for forming benzodiazepines
US3577557A (en) * 1966-12-09 1971-05-04 Sandoz Ag Benzo(1,5)diazocinones
US3723414A (en) * 1970-02-13 1973-03-27 Schering Corp 1-polyfluoroalkyl benzodiazepines
DE2166116A1 (de) * 1970-04-24 1973-02-15 Teikoku Hormone Mfg Co Ltd Verfahren zur herstellung von n-(dialkylaminoalkylen)-2-alkoxy(oder -alkenyloxy)4-amino-5-halogenbenzamiden
DK137857B (da) * 1970-09-03 1978-05-22 Takeda Chemical Industries Ltd Analogifremgangsmåde til fremstilling af 2-amino-1,5-benzodiazocinderivater eller farmaceutisk acceptable salte deraf.
JPS4728284Y1 (no) * 1970-09-14 1972-08-26
US4021224A (en) * 1971-12-09 1977-05-03 Stauffer Chemical Company Herbicide compositions
DE2265371C3 (de) * 1972-05-03 1980-12-11 Kali-Chemie Ag, 3000 Hannover N-(3-Benzoylaminopropyl)-aniline
US3975443A (en) * 1972-06-06 1976-08-17 Allen & Hanburys Limited 1-(3,4-dichlorobenzamidomethyl)-cyclohexyldimethylamine
GB1374366A (en) * 1972-07-21 1974-11-20 Science Union & Cie Propanol derivatives and a process for their preparation
US3957870A (en) * 1973-07-19 1976-05-18 Imperial Chemical Industries Limited Organic compounds

Also Published As

Publication number Publication date
FR2248278A1 (no) 1975-05-16
DK222977A (da) 1977-05-20
NO143347C (no) 1981-01-21
ES414279A1 (es) 1976-05-01
CH611608A5 (no) 1979-06-15
GB1429665A (en) 1976-03-24
CH605834A5 (no) 1978-10-13
NO145761C (no) 1982-05-26
BE799001A (fr) 1973-08-31
NO144885B (no) 1981-08-24
AT327920B (de) 1976-02-25
JPS5387385A (en) 1978-08-01
NO793012L (no) 1973-11-06
FR2183735B1 (no) 1976-09-03
DK144969B (da) 1982-07-19
AU5510173A (en) 1974-11-07
JPS5813535B2 (ja) 1983-03-14
SE7614680L (sv) 1976-12-29
ATA389973A (de) 1975-05-15
DE2221558C2 (de) 1982-12-02
NO144386C (no) 1981-08-19
ATA143875A (de) 1975-05-15
AT327919B (de) 1976-02-25
IL47693A (en) 1978-07-31
NO761580L (no) 1973-11-06
US4096141A (en) 1978-06-20
CA1009232A (en) 1977-04-26
IL48141A (en) 1978-07-31
DK147050B (da) 1984-03-26
CH620423A5 (no) 1980-11-28
NO142476B (no) 1980-05-19
NO145761B (no) 1982-02-15
NO143347B (no) 1980-10-13
FR2183735A1 (no) 1973-12-21
GB1429667A (en) 1976-03-24
JPS5387333A (en) 1978-08-01
NO142866C (no) 1980-11-05
US4243585A (en) 1981-01-06
GB1429666A (en) 1976-03-24
CH611607A5 (no) 1979-06-15
NO751349L (no) 1973-11-06
SE422460B (sv) 1982-03-08
ZA733013B (en) 1974-08-28
FR2248278B1 (no) 1977-11-04
SU526290A3 (ru) 1976-08-25
DE2265371C3 (de) 1980-12-11
DK144969C (da) 1982-12-06
DK147050C (da) 1984-09-03
SE7614681L (sv) 1976-12-29
US4595531A (en) 1986-06-17
DD105222A5 (no) 1974-04-12
DE2265371B2 (de) 1980-04-17
CA1020570A (en) 1977-11-08
SE409709B (sv) 1979-09-03
NL179111C (nl) 1986-07-16
US4216167A (en) 1980-08-05
AT327927B (de) 1976-02-25
CA984388A (en) 1976-02-24
NO780402L (no) 1973-11-06
DE2265370C2 (de) 1982-12-02
DK223077A (da) 1977-05-20
IL47693A0 (en) 1975-10-15
CH611609A5 (no) 1979-06-15
NO142866B (no) 1980-07-28
NO793013L (no) 1973-11-06
IL42158A (en) 1978-07-31
FR2296616A1 (fr) 1976-07-30
US3998809A (en) 1976-12-21
DE2221558A1 (de) 1973-11-15
NO144386B (no) 1981-05-11
FR2296616B1 (no) 1979-04-20
SU625607A3 (ru) 1978-09-25
IL48141A0 (en) 1975-11-25
US4098786A (en) 1978-07-04
JPS4941389A (no) 1974-04-18
NL7305570A (no) 1973-11-06
JPS5541231B2 (no) 1980-10-22
JPS589101B2 (ja) 1983-02-18
IL42158A0 (en) 1973-07-30
NO142476C (no) 1980-08-27
ATA389873A (de) 1975-05-15

Similar Documents

Publication Publication Date Title
NO144885C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater
NO141407C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater
NO145883C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7-methoxy-7-acylamino-cefalosporansyrederivater
NO145576C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive penicillinderivater
NO141687C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-oxo-2,2-disubstituerte-5-indanyloxy-eddiksyrer
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO146396C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO142865C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karbazoler
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO147109C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive diazepin-derivater
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO141648C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 2-oxazolinderivater
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO141651C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aroyl-substituerte fenyleddiksyrederivater
NO141161C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive morfinanderivater
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO140670C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
NO142260C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater
NO142077C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider
NO144110C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater
NO147485C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
NO142669C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, heterocykliske forbindelser